ClinVar Miner

Submissions for variant NM_004984.4(KIF5A):c.1932G>A (p.Thr644=)

gnomAD frequency: 0.00010  dbSNP: rs370644634
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000319934 SCV000380444 likely benign Hereditary spastic paraplegia 10 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001812799 SCV001474013 uncertain significance not provided 2023-10-26 criteria provided, single submitter clinical testing The KIF5A c.1932G>A, p.Thr644Thr variant (rs370644634), to our knowledge, has not been reported in the medical literature; however, this variant is listed in the ClinVar database (Variation ID: 309941). This variant is found in the general population with an overall allele frequency of 0.003% (10/282,866 alleles) in the Genome Aggregation Database. This variant does not alter the primary amino acid sequence of KIF5A; however, splice site prediction algorithms predict this variant may activate a cryptic splice acceptor. Although, without functional evidence, such predictions are not sufficient to assign pathogenicity. Thus, based on the available information, the clinical significance of this variant is uncertain.
Invitae RCV001306129 SCV001495488 likely benign Spastic paraplegia 2024-01-24 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003391112 SCV004119506 uncertain significance KIF5A-related condition 2023-01-06 criteria provided, single submitter clinical testing The KIF5A c.1932G>A variant is not predicted to result in an amino acid change (p.=). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.025% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/12-57969449-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.